EcoDrugPlus

Tyrosine-Protein Kinase Lyn-Like

Ensembl ID : ENSCVAG00000006450
Gene Symbol: LOC107091676
3 Cross references
196 Possible Orthologues:

Tyrosine-Protein Kinase Yes

Ensembl ID : ENSCVAG00000013689
Gene Symbol: LOC107099959
3 Cross references
187 Possible Orthologues:

Tyrosine-Protein Kinase Fyna

Ensembl ID : ENSCVAG00000003307
Gene Symbol: LOC107096191
3 Cross references
192 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSCVAG00000006506
Gene Symbol: VEGFA
3 Cross references
198 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSCVAG00000010528
Gene Symbol: VDR
3 Cross references
392 Possible Orthologues:

Vitamin D3 Receptor B

Ensembl ID : ENSCVAG00000018441
Gene Symbol: LOC107103431
3 Cross references
394 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1-Like Protein 1

Ensembl ID : ENSCVAG00000005598
Gene Symbol: LOC107097194
3 Cross references
191 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1c-Like

Ensembl ID : ENSCVAG00000011363
Gene Symbol: LOC107095494
3 Cross references
215 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1d-Like

Ensembl ID : ENSCVAG00000018635
Gene Symbol: LOC107094760
3 Cross references
212 Possible Orthologues:

Voltage-Dependent P/q-Type Calcium Channel Subunit Alpha-1a-Like

Ensembl ID : ENSCVAG00000012086
Gene Symbol: LOC107084276
3 Cross references
196 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-1 Subunit-Like

Ensembl ID : ENSCVAG00000014461
Gene Symbol: LOC107084716
3 Cross references
196 Possible Orthologues:

Voltage-Dependent Calcium Channel Gamma-3 Subunit-Like

Ensembl ID : ENSCVAG00000015976
Gene Symbol: LOC107086415
2 Cross references
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).